April 24, 2014 1:36 PM ET


Company Overview of Sunovion Respiratory Development Inc.

Executive Profile

Bill Gerhart

Co-Founder, President and Director, Sunovion Respiratory Development Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Mr. Bill Gerhart Co-founded Elevation Pharmaceuticals, Inc., in 2007 and serves as its Chief Executive Officer and President. Mr. Gerhart serves as the Chief Executive Officer of Medlyte Diagnostics, Inc. He is leading Medlyte Diagnostics, Inc.'s fundraising efforts and is overseeing its introduction of its first lead candidate into pre-clinical testing. Mr. Gerhart is an experienced Founder and Chief Executive Officer with more than 15 years experience starting and ...

Corporate Headquarters

11455 El Camino Real
San Diego, California 92130

United States

Phone: 858-436-1616
Fax: 858-436-1605

Board Members Memberships

Former Director
Co-Founder, President and Director


Harvard Business School
Bachelor's Degree
Baylor University
Baylor University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sunovion Respiratory Development Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.